Variations in antimicrobial use and cost in more than 2,000 patients with community-acquired pneumonia

The American Journal of Medicine
K GilbertM J Fine

Abstract

To assess the patterns of antimicrobial use, costs of antimicrobial therapy, and medical outcomes by institution in patients with community-acquired pneumonia. The route, dose, and frequency of administration of all antimicrobial agents prescribed within 30 days of presentation were recorded for 927 outpatients and 1328 inpatients enrolled in the Pneumonia Patient Outcomes Research Team (PORT) multicenter, prospective cohort study. Total antimicrobial costs were estimated by summing drug costs, using average wholesale price for oral agents and institutional acquisition prices for parenteral agents, plus the costs associated with preparation and administration of parenteral therapy. Thirty-day outcome measures were mortality, subsequent hospitalization for outpatients, and hospital readmission for inpatients. Significant variation (P <0.05) in prescribing practices occurred for 17 of the 23 antimicrobial agents used in outpatients across 5 treatment sites, and for 18 of the 20 parenteral agents used in inpatients across 4 treatment sites. The median duration of antimicrobial therapy for treatment site ranged from 11 to 13 days for outpatients (P=0.01), and from 13 to 15 days for inpatients (P=0.49). The overall median cost of an...Continue Reading

Citations

Aug 7, 2003·The Lancet Infectious Diseases·Gavin D BarlowDilip Nathwani
May 17, 2003·Clinical Therapeutics·Sanjay MerchantYa-Chen Tina Shih
Jan 17, 2003·LDI Issue Brief·Joshua P Metlay
Oct 3, 2003·Journal of General Internal Medicine·Galen E SwitzerMichael J Fine
Oct 13, 2000·Journal of General Internal Medicine·J A BrandenburgM J Fine
Jun 13, 1998·Journal of General Internal Medicine·P P GleasonB M Psaty
Nov 20, 2001·Thorax·UNKNOWN British Thoracic Society Standards of Care Committee
Mar 25, 2008·Therapeutics and Clinical Risk Management·Anita G Carrie, Thomas J Marrie
Nov 30, 2000·Current Infectious Disease Reports·M B Kanno, P D Brown
Jan 26, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph P Lynch III, Fernando J Martinez
Mar 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D NathwaniP Davey
Feb 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·N SinghI R Marino
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B RosónF Gudiol
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E RubinsteinUNKNOWN Linezolid Nosocomial Pneumonia Study Group
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Fernando J Martinez
Sep 28, 2001·International Journal of Antimicrobial Agents·L Mulazimoglu
Nov 16, 2010·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Yuan-Yu JengCheng-Yi Liu
May 13, 1999·The American Journal of Medicine·A S DunnL G Smith
Mar 18, 2006·International Journal of Antimicrobial Agents·Michael S Niederman
Apr 21, 2006·Basic & Clinical Pharmacology & Toxicology·Jakob E BorchC Bindslev-Jensen
Jun 6, 2009·Respiratory Research·Eric M MortensenAntonio Anzueto
Feb 14, 2006·Critical Care : the Official Journal of the Critical Care Forum·Ritesh Agarwal
Feb 28, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Thomas J. MarrieWishwa N. Kapoor
Sep 30, 2006·The Journal of Infection·Yvonne KohlhammerUNKNOWN CAPNETZ study group
Dec 11, 2007·The Journal of Antimicrobial Chemotherapy·Gavin BarlowPeter Davey
Apr 7, 2004·European Journal of Internal Medicine·Olivier LamyBernard Burnand
Mar 1, 2005·Respiratory Medicine·Alberto CapelasteguiAmaia Bilbao
Sep 13, 2003·The International Journal of Health Planning and Management·Kehui LiuRainer Sauerborn
Jun 18, 2011·Social Psychiatry and Psychiatric Epidemiology·Peter ButterworthMargaret Kelaher
Apr 9, 2010·Journal of Cross-cultural Gerontology·Malcolm P CutchinRebecca M Aldrich
Jul 8, 2011·Clinical Microbiology Reviews·Trevor Winstanley, Patrice Courvalin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.